Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers
Article in OncoTargets and Therapy (July 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Synthetic lethality between CCNE1 hyperactivity and PARG inhibition in breast cancer
Preprint in Research Square (November 2022)
PTEN Loss Enhances Error-Prone DSB Processing and Tumor Cell Radiosensitivity by Suppressing RAD51 Expression and Homologous Recombination
Article in International Journal of Molecular Sciences (October 2022)